Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells.
将 FDA 批准的药物重新用于抑制胶质母细胞瘤细胞中治疗诱导的侵袭伪足活性
期刊:Molecular and Cellular Biochemistry
影响因子:3.7
doi:10.1007/s11010-022-04584-0
Jones Dylan, Whitehead Clarissa A, Dinevska Marija, Widodo Samuel S, Furst Liam M, Morokoff Andrew P, Kaye Andrew H, Drummond Katharine J, Mantamadiotis Theo, Stylli Stanley S
